The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer
Therapeutics held in Washington, DC on 16–19 November 1999 provided a forum for …

Targeted therapies can be defined as drugs developed against a specific target based on its
important biological function in cancer. In contrast, nontargeted therapies are drugs …

The International Conference on Molecular Targets and Therapeutics, jointly sponsored by
the American Association for Cancer Research (AACR), National Cancer Institute (NCI) and …

Through novel methodologies, including both basic and clinical research, progress has
been made in the therapy of solid cancer. Recent innovations in anticancer therapies …

Significant progress has been made in our understanding of the molecular lesions
responsible for tumor cells to exhibit uncontrolled growth while circumventing normal …

The last decades were characterized by enormous technological advances resulting in a
better understanding of disease pathologies and improvement of treatment strategies. The …

In recent decades, targeted therapeutics have significantly improved therapy results in
patients with malignant tumors of different origins. However, malignant diseases …

Targeted therapies have changed the course of cancer treatment in recent years. By
reducing toxicity and improving outcome, these new generations of precision medicines …

Cancer has become a major public health problem worldwide. Researches focus on the
new approaches for cancer treatments that involve the specific targets of the cancer disease …

Cancer is an abnormal state of cells where they undergo uncontrolled proliferation and
produce aggressive malignancies that causes millions of deaths every year. With the new …